Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
GfV 2023
Programm
Poster
Personen
Suche
DE
Alle Personen
Dr. Alexandra Herrmann
Gräfelfing / DE
Immunic AG
Sortiert nach Typ
Datum
Vortrag
28.03.2023
Poster
P 022
Preclinical development of optimized DHODH inhibitors as broad-spectrum antivirals for the treatment of respiratory virus infections
Antiviral therapy and resistance, Host cell factors and modulation
Weitere Beteiligungen
28.03.2023
Poster
P 104
Characterization of monkeypox virus from Franconia (Bavaria, Germany) and antiviral testing of patient isolates
Antiviral therapy and resistance, Emerging viruses and zoonosis
28.03.2023
Poster
P 230
SARS-CoV-2 ORF3c suppresses the induction of IFN-β
SARS-CoV-2, Viral pathogenesis and persistence
28.03.2023
Poster
P 022
Preclinical development of optimized DHODH inhibitors as broad-spectrum antivirals for the treatment of respiratory virus infections
Antiviral therapy and resistance, Host cell factors and modulation
28.03.2023
Poster
P 260
Generation of SARS-CoV-2 Bacmids containing large fragments of Omicron as a new strategy to analyse its pathology and virulence
SARS-CoV-2, Viral replication strategies 1 (RNA viruses)
30.03.2023
09:00
–
09:15
12 Min.
3 Min.
Abstract Talk
O 075
Gammaherpesviral tegument proteins inhibit the DNA damage response and target SMC proteins
Host cell factors and modulation, Viral transformation and oncogenesis
30.03.2023
09:45
–
10:00
12 Min.
3 Min.
Abstract Talk
O 084
Selective small molecules directed to nuclear receptor RORγ isoform 1 exhibit a broad antiviral potential through metabolic restriction of virus replication
Antiviral therapy and resistance, Host cell factors and modulation
30.03.2023
14:30
–
14:45
12 Min.
3 Min.
Abstract Talk
O 089
2'-O-methylation of SARS-CoV-2 RNA regulates innate immune sensing by MDA5
Innate immunity, SARS-CoV-2
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz